Statins are recommended for four major groups of people: those who already have cardiovascular disease, those with very high LDL cholesterol (190 mg/dL or above), adults aged 40 to 75 with diabetes, and people whose estimated 10-year risk of a heart attack or stroke is high enough to justify treatment. Where you fall among these groups determines not just whether you should take a statin, but how aggressive the dose should be.
People Who Already Have Cardiovascular Disease
If you’ve had a heart attack, stroke, mini-stroke, or been diagnosed with peripheral artery disease or an aortic aneurysm caused by plaque buildup, statins aren’t optional. This is called secondary prevention, and guidelines recommend high-intensity statin therapy for adults 75 and younger with any of these conditions. The goal is to cut your LDL cholesterol by at least 50%. People who’ve had coronary bypass surgery, stent placement, or been diagnosed with stable or unstable angina also fall into this category.
The evidence here is the strongest of any group. High-intensity typically means a higher dose of one of the more potent statins. The benefit is large enough that it applies regardless of what your cholesterol numbers look like at the time.
Very High LDL Cholesterol
An LDL cholesterol level of 190 mg/dL or higher triggers a recommendation for high-intensity statin therapy starting at age 20, without any need for a risk calculator. At that level, the cholesterol itself is dangerous enough to justify treatment on its own. This threshold often catches people with familial hypercholesterolemia, a genetic condition that keeps LDL elevated from a young age, though anyone with severely high LDL qualifies regardless of the cause.
Because sustained high LDL accelerates plaque buildup in arteries over decades, early treatment in this group can prevent heart disease that would otherwise develop well before middle age.
Adults With Diabetes
Diabetes significantly increases cardiovascular risk, so current guidelines from both the American Diabetes Association and the ACC/AHA recommend moderate-intensity statin therapy for all people with diabetes between the ages of 40 and 75, even if they have no signs of heart disease. A moderate-intensity statin lowers LDL cholesterol by 30 to 49%.
If you have diabetes along with additional risk factors, such as high blood pressure, smoking, or a family history of early heart disease, your doctor may recommend stepping up to high-intensity therapy. For people with diabetes younger than 40, or those with type 1 diabetes, the decision is more individualized. Guidelines suggest weighing personal risk factors and discussing the tradeoffs rather than automatically starting medication.
The 10-Year Risk Calculation
For adults aged 40 to 75 without diabetes or existing cardiovascular disease, the decision hinges on a 10-year risk estimate. This calculation uses your age, sex, race, blood pressure (and whether it’s treated), total cholesterol, HDL cholesterol, smoking status, and whether you have diabetes. Some newer models also incorporate kidney function and family history of heart disease.
The resulting percentage places you into one of several tiers:
- Below 5%: Low risk. Statins are generally not recommended for primary prevention.
- 5% to 7.5%: Borderline risk. A statin may be considered if other factors tip the balance.
- 7.5% to 20%: Intermediate risk. This is the range where the conversation between you and your clinician matters most. A moderate-intensity statin is reasonable, but additional information can help clarify the decision.
- Above 20%: High risk. Statin therapy is strongly recommended.
Many people land in that intermediate zone, which is where the decision can feel murky. That’s where risk-enhancing factors and imaging tests come in.
When the Decision Isn’t Clear-Cut
For people in the borderline or intermediate risk range (5% to 20% over 10 years), a coronary artery calcium scan can act as a tiebreaker. This quick CT scan measures calcified plaque in the arteries of the heart and produces a score that sharpens the picture considerably.
A calcium score of zero means very low risk. In that case, it’s reasonable to skip statins and recheck the scan in five to ten years. A score of 1 to 99 mildly increases estimated risk and favors starting a statin, particularly after age 55. A score above 100 puts you in territory where statin therapy is recommended. Scores above 300 point toward high-intensity treatment.
Other factors that can push a borderline decision toward treatment include a family history of premature heart disease, South Asian ancestry, chronic kidney disease, chronic inflammatory conditions like rheumatoid arthritis, elevated inflammatory markers, or a history of preeclampsia or early menopause.
Adults Over 75
If you’re already taking a statin and turn 75, continuing it is generally well-supported. The more uncertain question is whether to start one for the first time at that age. The 2018 ACC/AHA guidelines describe it as “reasonable to consider” initiating moderate-intensity statin therapy for adults over 75 with LDL cholesterol between 70 and 189 mg/dL. The evidence leans toward benefit, but the data from randomized trials thins out beyond age 79, so the decision requires a more careful individual conversation about life expectancy, other medications, and personal priorities.
For secondary prevention (meaning you already have heart disease), age alone is not a reason to stop. The benefit of continuing statins in older adults with established cardiovascular disease remains strong.
What About Side Effects
Muscle pain is the most commonly cited reason people stop or avoid statins, but the actual risk is smaller than many people assume. In double-blind trials where neither the patient nor the doctor knows who’s getting the real drug, muscle symptoms occur at nearly identical rates in statin and placebo groups. One large trial found muscle-related side effects in 2.03% of people taking a statin versus 2.00% of those on a placebo.
Observational studies, where patients know they’re taking a statin, report much higher rates, sometimes 10 to 20%. This gap strongly suggests that expectation plays a role. In one telling study, 43% of people with a history of statin-related muscle complaints reported symptoms when they knew they were taking a statin, but 27% also reported the same symptoms on placebo. That said, a small number of people do experience genuine statin-related muscle problems. Switching to a different statin or adjusting the dose resolves the issue for most of them.
High-Intensity vs. Moderate-Intensity
Not everyone who qualifies for a statin needs the same dose. High-intensity therapy aims to lower LDL by 50% or more and is reserved for people with existing cardiovascular disease, very high LDL, or high overall risk. Moderate-intensity therapy lowers LDL by 30 to 49% and is the starting point for most people with diabetes or intermediate risk.
In practice, your clinician will choose a specific statin and dose based on which intensity level you need, how you tolerate the medication, and how much your LDL actually drops. The goal isn’t a single magic number for everyone. It’s matching the strength of treatment to the size of the risk.